Hisamitsu Pharmaceutical Co Inc (HTSUF)
24.56
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Hisamitsu Pharmaceutical Total Assets (Quarterly): 2.182B for Feb. 29, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| February 29, 2024 | 2.182B |
| November 30, 2023 | 2.277B |
| August 31, 2023 | 2.356B |
| May 31, 2023 | 2.290B |
| February 28, 2023 | 2.302B |
| November 30, 2022 | 2.428B |
| August 31, 2022 | 2.363B |
| May 31, 2022 | 2.408B |
| February 28, 2022 | 2.620B |
| November 30, 2021 | 2.671B |
| August 31, 2021 | 2.815B |
| May 31, 2021 | 2.728B |
| February 28, 2021 | 2.813B |
| November 30, 2020 | 2.849B |
| August 31, 2020 | 2.832B |
| May 31, 2020 | 2.756B |
| February 29, 2020 | 2.844B |
| November 30, 2019 | 2.813B |
| August 31, 2019 | 2.791B |
| May 31, 2019 | 2.647B |
| February 28, 2019 | 2.668B |
| November 30, 2018 | 2.710B |
| August 31, 2018 | 2.746B |
| May 31, 2018 | 2.699B |
| February 28, 2018 | 2.791B |
| Date | Value |
|---|---|
| November 30, 2017 | 2.667B |
| August 31, 2017 | 2.619B |
| May 31, 2017 | 2.528B |
| February 28, 2017 | 2.472B |
| November 30, 2016 | 2.420B |
| August 31, 2016 | 2.684B |
| May 31, 2016 | 2.552B |
| February 29, 2016 | 2.505B |
| November 30, 2015 | 2.382B |
| August 31, 2015 | 2.428B |
| May 31, 2015 | 2.302B |
| February 28, 2015 | 2.391B |
| November 30, 2014 | 2.314B |
| August 31, 2014 | 2.574B |
| May 31, 2014 | 2.473B |
| February 28, 2014 | 2.466B |
| November 30, 2013 | 2.422B |
| August 31, 2013 | 2.492B |
| May 31, 2013 | 2.236B |
| February 28, 2013 | 2.319B |
| November 30, 2012 | 2.481B |
| August 31, 2012 | 2.592B |
| May 31, 2012 | 2.502B |
| February 29, 2012 | 2.395B |
| November 30, 2011 | 2.487B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
2.182B
Minimum
Feb 2024
2.849B
Maximum
Nov 2020
2.586B
Average
2.671B
Median
Nov 2021
Total Assets (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 99.82B |
| Nxera Pharma Co Ltd | 1.006B |
| PeptiDream Inc | 460.09M |
| Healios KK | 108.91M |
| AnGes Inc | 185.19M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 409.58M |
| Shareholders Equity (Quarterly) | 1.758B |
| Debt to Equity Ratio | 0.0043 |
| Current Ratio | 4.224 |
| Net Debt Paydown Yield | 0.01% |